Stabilizers and their interaction with formulation components in frozen and freeze-dried protein formulations

S Thakral, J Sonje, B Munjal… - Advanced drug delivery …, 2021 - Elsevier
This review aims to provide an overview of the current knowledge on protein stabilization
during freezing and freeze-drying in relation to stress conditions commonly encountered …

[HTML][HTML] Understanding and controlling the molecular mechanisms of protein aggregation in mAb therapeutics

KT Pang, YS Yang, W Zhang, YS Ho, P Sormanni… - Biotechnology …, 2023 - Elsevier
In antibody development and manufacturing, protein aggregation is a common challenge
that can lead to serious efficacy and safety issues. To mitigate this problem, it is important to …

Embedding dynamics in intrinsic physicochemical profiles of market-stage antibody-based biotherapeutics

G Licari, KP Martin, M Crames, J Mozdzierz… - Molecular …, 2022 - ACS Publications
Adequate stability, manufacturability, and safety are crucial to bringing an antibody-based
biotherapeutic to the market. Following the concept of holistic in silico developability, we …

[HTML][HTML] Engineering stability, viscosity, and immunogenicity of antibodies by computational design

D Kuroda, K Tsumoto - Journal of Pharmaceutical Sciences, 2020 - Elsevier
In recent years, computational methods have garnered much attention in protein
engineering. A large number of computational methods have been developed to analyze the …

Computational Characterization of Antibody–Excipient Interactions for Rational Excipient Selection Using the Site Identification by Ligand Competitive Saturation …

S Jo, A Xu, JE Curtis, S Somani… - Molecular …, 2020 - ACS Publications
Protein therapeutics typically require a concentrated protein formulation, which can lead to
self-association and/or high viscosity due to protein–protein interaction (PPI). Excipients are …

Flow activation energy of high-concentration monoclonal antibody solutions and protein–protein interactions influenced by NaCl and sucrose

G Yuan, PF Salipante, SD Hudson… - Molecular …, 2024 - ACS Publications
The solution viscosity and protein–protein interactions (PPIs) as a function of temperature (4–
40° C) were measured at a series of protein concentrations for a monoclonal antibody (mAb) …

[HTML][HTML] The search for novel proline analogs for viscosity reduction and stabilization of highly concentrated monoclonal antibody solutions

M Prašnikar, M Proj, MB Žiberna, B Lebar… - International journal of …, 2024 - Elsevier
Administration of monoclonal antibodies (mAbs) is currently focused on subcutaneous
injection associated with increased patient adherence and reduced treatment cost, leading …

An experimental approach probing the conformational transitions and energy landscape of antibodies: a glimmer of hope for reviving lost therapeutic candidates using …

TA Shmool, LK Martin, L Bui-Le, I Moya-Ramirez… - Chemical …, 2021 - pubs.rsc.org
Understanding protein folding in different environmental conditions is fundamentally
important for predicting protein structures and developing innovative antibody formulations …

Computational models for studying physical instabilities in high concentration biotherapeutic formulations

MA Blanco - MAbs, 2022 - Taylor & Francis
Computational prediction of the behavior of concentrated protein solutions is particularly
advantageous in early development stages of biotherapeutics when material availability is …

Machine learning models of antibody–excipient preferential interactions for use in computational formulation design

TK Cloutier, C Sudrik, N Mody, HA Sathish… - Molecular …, 2020 - ACS Publications
Preferential interactions of formulation excipients govern their impact on the stability
properties of proteins in solution. The ability to predict these interactions without the need to …